Bayer Withdraws from US Settlement Proceedings

  • 27 May 2021
  • by
  • Comments Off on Bayer Withdraws from US Settlement Proceedings

Defeat for Bayer boss Werner Baumann in the legal dispute over glyphosate: The responsible US federal judge has rejected the proposed settlement. Bayer is therefore now stepping out of the…

Read More

Bayer is Also Subject to the Second Glyphosate Appeal

  • 15 May 2021
  • by
  • Comments Off on Bayer is Also Subject to the Second Glyphosate Appeal

The agrochemical and pharmaceutical company Bayer has also suffered a defeat in the second of its US appeals proceedings due to alleged cancer risks of the weed killer glyphosate. The…

Read More

Bayer Made A Loss of More Than 10 Billion Euros

  • 25 February 2021
  • by
  • Comments Off on Bayer Made A Loss of More Than 10 Billion Euros

The pharmaceutical and chemical giant has had a difficult year. The settlement of the glyphosate lawsuits in the USA and billions in write-offs in the agricultural business resulted in a…

Read More

Bayer is Investing up to Four Billion Dollars in Gene Therapy Specialists

  • 26 October 2020
  • by
  • Comments Off on Bayer is Investing up to Four Billion Dollars in Gene Therapy Specialists

With its largest acquisition to date in the biotech sector, Bayer aims to become a leading player in gene and cell therapy. The Leverkusen-based group is taking over the non-listed…

Read More

Page 1 of 1